Replies to post #795613 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Iron Mike, you could be right, but as I understand it, NWBO's filing was largely made by contractors with expertise in such filings, NWBO certainly didn't have the staff to do it in house

I never got first hand feedback from the company regarding this, but there have been multiple reports here, including from Senti who is wildly sympathetic to management and in open communication with them, that the company had such major issues with the contractors hired to assist with the MAA that they eventually had to cut ties and finish the MAA themselves.

So yes, it is perfectly reasonable to assume that the MAA was extremely low quality.

[FeMike]

I do believe we'll get an approval, if the regulators didn't intend that they'd have kicked it back ages ago.

In the realm of probabilities, I would agree with you here.

If it was getting rejected, the MHRA wouldn't accommodate NWBO asking them to delay the decision so the company can continue diluting. In the realm of speculations, there really aren't any valid arguments I've seen for why this process would be taking this long only to get rejected.

Nothing's off the table, but the length of time only increases the likelihood for approval by my measure. Unfortunately it also massively increases dilution.